APA (7th ed.) Citation

Singh, N., & Kumari, A. (2026). Comparison of Tolerance and Survival Outcomes of Dosedense Weekly Paclitaxel against 3-weekly Therapy for Epithelial Ovarian Cancer. Journal of South Asian Federation of Obstetrics & Gynecology, 18(1), 54. https://doi.org/10.5005/jp-journals-10006-2846

Chicago Style (17th ed.) Citation

Singh, Nisha, and Aparna Kumari. "Comparison of Tolerance and Survival Outcomes of Dosedense Weekly Paclitaxel Against 3-weekly Therapy for Epithelial Ovarian Cancer." Journal of South Asian Federation of Obstetrics & Gynecology 18, no. 1 (2026): 54. https://doi.org/10.5005/jp-journals-10006-2846.

MLA (9th ed.) Citation

Singh, Nisha, and Aparna Kumari. "Comparison of Tolerance and Survival Outcomes of Dosedense Weekly Paclitaxel Against 3-weekly Therapy for Epithelial Ovarian Cancer." Journal of South Asian Federation of Obstetrics & Gynecology, vol. 18, no. 1, 2026, p. 54, https://doi.org/10.5005/jp-journals-10006-2846.